A61K 31/58
Containing heterocyclic rings
Official title: containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048})
A61K31/58 (Containing heterocyclic rings) appears on 2,162 US grants and 4,001 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,162
- Published applications
- 4,001
- Assignees
- 1,527
- Inventors
- 5,963
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 4 | 0 |
| 1982 | 8 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 10 | 0 |
| 1990 | 6 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 8 | 0 |
| 1994 | 14 | 0 |
| 1995 | 7 | 0 |
| 1996 | 24 | 0 |
| 1997 | 27 | 0 |
| 1998 | 34 | 0 |
| 1999 | 45 | 0 |
| 2000 | 31 | 0 |
| 2001 | 38 | 14 |
| 2002 | 39 | 64 |
| 2003 | 33 | 112 |
| 2004 | 25 | 111 |
| 2005 | 22 | 98 |
| 2006 | 20 | 96 |
| 2007 | 20 | 95 |
| 2008 | 16 | 80 |
| 2009 | 26 | 120 |
| 2010 | 34 | 123 |
| 2011 | 53 | 118 |
| 2012 | 64 | 147 |
| 2013 | 67 | 152 |
| 2014 | 103 | 206 |
| 2015 | 86 | 212 |
| 2016 | 122 | 222 |
| 2017 | 132 | 246 |
| 2018 | 132 | 208 |
| 2019 | 141 | 215 |
| 2020 | 145 | 202 |
| 2021 | 109 | 235 |
| 2022 | 121 | 222 |
| 2023 | 108 | 195 |
| 2024 | 96 | 204 |
| 2025 | 96 | 176 |
| 2026 | 41 | 128 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods comprising endothelin a receptor antagonists and androgen therapies29 Sep 2026US 12,746,239 B2The United States Government as represented by the Department of Veterans Affairs
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- Withanolide-enriched compositions and methods of use thereof22 Sep 2026US 12,741,005 B2
- Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone15 Sep 2026US 12,734,180 B2Janssen Pharmaceutica NV
- Methods for treating nasal polyposis by administering an IL-4R antagonist18 Aug 2026US 12,709,642 B2Regeneron Pharmaceuticals, Inc.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Stable corticosteroid compositions8 Oct 2026US 2026/0306511 A1Viropharma Biologics LLC
- Methods for treating or preventing asthma by administering an il-4r antagonist8 Oct 2026US 2026/0306627 A1Regeneron Pharmaceuticals, Inc.
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof1 Oct 2026US 2026/0294884 A1Insilico Medicine IP Limited
Most cited
By later US patents
- Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof317US 6,375,972 B1Control Delivery Systems, Inc. · 2002
- Ocular therapeutic agent delivery devices and methods for making and using such devices277US 6,713,081 B2The United States of America as represented by the Department of Health and Human Services · 2004
- Method for treating infectious respiratory diseases270US 5,290,540 AThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 1994
- Aqueous compositions containing corticosteroids for nasal and pulmonary delivery172US 6,241,969 B1Elan Corporation, plc · 2001
- Methods for treating inflammatory conditions167US 6,190,691 B1Adolor Corporation · 2001